Teva Pharmaceutical Industries ADR (TEVA)

$16.82 0.00 (0.00%)

17:00 EDT TEVA Stock Quote Delayed 30 Minutes

7 A-Rated Biotech Stocks Worth Betting on in June

By Louis Navellier and the InvestorPlace Research Staff Jun 14, 2024

A-rated biotech stocks are highly coveted because they are at the forefront — or in the midst of — groundbreaking innovation.

Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade

TEVA Stock Earnings: Teva Pharmaceutical Indus Misses EPS, Beats Revenue for Q1 2024

TEVA Stock Pops 4% as Teva Receives FDA Approval

Volume:

Previous Close -

Market Cap 18.68B

PE Ratio -120.14

EPS -0.14

Volume (Avg. Vol.) 3,468

Day's Range -

52-Week Range $7.42 - $17.69

Dividend & Yield N/A (N/A)

TEVA Stock Predictions, Articles, and Teva Pharmaceutical Industries ADR News

Israeli Stocks Fall as Investors Fear Middle East Conflict

By Samuel O'Brient, InvestorPlace Reporter Oct 9, 2023

The recent attacks on Israel will have a lasting economic impact. Here's what investors should know about Israeli stocks.

Why Is Teva Pharmaceuticals (TEVA) Stock Up Today?

By William White, InvestorPlace Writer May 18, 2023

Teva Pharmaceuticals (TEVA) stock is climbing higher on Thursday after the pharmaceutical company announced a new growth strategy.

7 Strong Buy Stocks Under $10 to Snap Up Now

By Chris Lau, InvestorPlace Contributor Mar 23, 2023

Markets are missing out on these seven strong buy stocks under $10, which trade at too good a value score for savvy investors to ignore.

TEVA Stock Alert: What to Know About Teva Pharmaceuticals’ New CEO

By William White, InvestorPlace Writer Nov 21, 2022

Teva Pharmaceuticals (TEVA) stock is sliding on Monday after the company announced Richard Francis as its newest president and CEO.

TEVA Stock Surges 24% as Teva Pharmaceuticals Settles Lawsuits

By William White, InvestorPlace Writer Jul 27, 2022

Teva Pharmaceuticals (TEVA) stock is soaring higher on Wednesday after the pharmaceutical company reached a settlement in recent lawsuits.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Jul 27, 2022

Good morning, investor! Wednesday starts with a breakdown of the biggest pre-market stock movers for traders to keep an eye on!

What Is Going on With Teva Pharmaceuticals (TEVA) Stock Today?

By David Moadel, InvestorPlace Contributor Jul 12, 2022

TEVA stock, already trading far below its prior peak, may come under pressure in the near future due to the threat of ongoing litigation.

7 Drug Stocks to Consider After the Viatris Plunge

By Thomas Niel, InvestorPlace Contributor Mar 10, 2022

As Viatris and other generic drug makers plunge, what should you buy instead? Consider these seven well-known drug stocks, all of which are good value in what's still a pricey market.

7 Stocks to Buy That Are Nowhere Near Being Overvalued

By Chris Lau, InvestorPlace Contributor Jan 18, 2022

These stocks to buy are above their lows and appear overvalued. They have more upside as growth drivers emerge lifting their prospects.

7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts

By Thomas Niel, InvestorPlace Contributor Dec 7, 2021

These seven drug stocks, a mix of growth, value, and moonshot plays, each stand to see big moves in the next twelve months.

The 7 Best Warren Buffett Stocks to Buy in August and Hold for Years

By Tezcan Gecgil, InvestorPlace Contributor Jul 29, 2021

These Buffett stocks are suitable for a wide range of retail portfolios. Check out 7 of the Omaha Oracle's top stocks to buy for August.

8 Cheap Stocks Under $20 That Could Double

By Josh Enomoto, InvestorPlace Contributor Feb 11, 2021

Even though the market has been on fire recently, that doesn’t mean you’re too late to pick up cheap stocks under $20 with 2x (or more) potential.

7 Stocks That Could Make You a Millionaire

By Tezcan Gecgil, InvestorPlace Contributor Jan 12, 2021

With proper research and long-term investing, $1 million can easily be in reach. Check out these stocks that could make you a millionaire.

4 Warren Buffett Stocks He Should Sell

By Vince Martin, InvestorPlace Contributor Jan 5, 2021

Warren Buffett stocks have been a mixed bag during this bull market. These four names are the weakest in Berkshire's portfolio.

7 Undervalued Stocks With Massive Potential

By Chris Lau, InvestorPlace Contributor Sep 21, 2020

The stock market may have forgotten about these seven undervalued stocks, but you can pick them up now on the cheap.

7 Cheap Stocks to Buy Under $10

By Chris Lau, InvestorPlace Contributor Sep 21, 2020

Price-to-earnings are one way to find value but there are cheap stocks to buy based on stock price, from technology to manufacturing.

7 Cheap Stocks for the Cash-Strapped Investor

By Chris Lau, InvestorPlace Contributor Sep 2, 2020

Investors have many cheap stocks to buy, using widely-followed metrics or by looking at those lacking institutional interest.

9 Companies to Invest In as U.S.-China Relations Deteriorate

By Josh Enomoto, InvestorPlace Contributor Aug 18, 2020

The devastation of the coronavirus was the last straw for the Trump administration, prompting an aggressive approach to U.S.-China relations. Here are some of the top companies to invest in to account for this foreign policy shift.

8 Cheap Stocks to Keep on Your Short List

By Josh Enomoto, InvestorPlace Contributor Aug 13, 2020

Due to the disjointed fundamentals, many investors were caught off guard with this current bull market. However, there are cheap stocks to buy that are still available.

10 Stocks to Buy for Your 10-Year-Old

By Josh Enomoto, InvestorPlace Contributor Aug 7, 2020

With digitalization trends changing how we live and work, these ten stocks to buy are perfect for your long-term portfolio – or your young children’s.

Teva Pharmaceutical Industries ADR (TEVA)

7 A-Rated Biotech Stocks Worth Betting on in June

Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade

TEVA Stock Earnings: Teva Pharmaceutical Indus Misses EPS, Beats Revenue for Q1 2024

TEVA Stock Pops 4% as Teva Receives FDA Approval

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Teva Pharmaceutical Industries ADR (TEVA)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

TEVA Stock Predictions, Articles, and Teva Pharmaceutical Industries ADR News

Subscriber Sign in